ArticleRespiratory medicine case reports2017

Immunotherapy "Shock" a case series of PD-L1 100% and pembrolizumab first-line treatment.

Paul Zarogoulidis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.